20-hydroxy-5,8,11,14-eicosatetraenoic acid has been researched along with angiotensin ii in 34 studies
Studies (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Trials (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Recent Studies (post-2010) (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Studies (angiotensin ii) | Trials (angiotensin ii) | Recent Studies (post-2010) (angiotensin ii) |
---|---|---|---|---|---|
640 | 13 | 233 | 38,152 | 1,089 | 7,413 |
Protein | Taxonomy | 20-hydroxy-5,8,11,14-eicosatetraenoic acid (IC50) | angiotensin ii (IC50) |
---|---|---|---|
Atrial natriuretic peptide receptor 3 | Homo sapiens (human) | 0.002 | |
Type-1A angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.002 | |
Type-1B angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0018 | |
Type-1 angiotensin II receptor | Homo sapiens (human) | 0.0055 | |
Type-2 angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.004 | |
Type-2 angiotensin II receptor | Homo sapiens (human) | 0.0011 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (11.76) | 18.2507 |
2000's | 17 (50.00) | 29.6817 |
2010's | 12 (35.29) | 24.3611 |
2020's | 1 (2.94) | 2.80 |
Authors | Studies |
---|---|
Balazy, M; Falck, JR; Lu, M; Reddy, KM; Wang, W; Zhu, Y | 1 |
Amlal, H; Bichara, M; LeGoff, C; Paillard, M; Soleimani, M; Vernimmen, C | 1 |
Benter, IF; Fatima, S; Harper, J; Karzoun, N; Malik, KU; Muthalif, MM; Uddin, MR | 1 |
George, T; Good, DW; Wang, DH | 1 |
Falck, JR; Frisbee, JC; Lombard, JH | 1 |
Escalante, B; López-Sánchez, P; Martínez-Ayala, S; Rios, A; Sánchez-Mendoza, A; Vázquez-Cruz, B | 1 |
Carroll, MA; Croft, KD; McGiff, JC; Sanchez-Mendoza, A | 1 |
Malik, KU; Muthalif, MM; Nishimoto, AT; Parmentier, JH | 1 |
Abe, M; Arima, S; Chiba, Y; Endo, Y; Ito, O; Ito, S; Kohagura, K; Omata, K | 1 |
Alonso-Galicia, M; Cowley, AW; Greene, AS; Maier, KG; Roman, RJ | 1 |
Capparelli, MF; Carroll, MA; Cheng, MK; Doumad, AB; Jiang, H; McGiff, JC | 1 |
Carroll, MA; Escalante, BA; Ferreri, NR; McGiff, JC; Oyekan, AO | 1 |
Brandes, RP; Busse, R; Fleming, I; Hammock, BD; Jung, O; Kim, IH; Schmidt, R; Schweda, F | 1 |
Bohman, Q; Flasch, A; Roman, RJ; Stec, DE; Taylor, M; Vera, T | 1 |
Estes, AM; Jafari, N; Malik, KU; Parmentier, JH; Schaefer, SA; Yaghini, FA; Zhang, C | 1 |
Bolad, I; Delafontaine, P | 1 |
Caron, N; Flamion, B; Imig, JD; Joly, E; Kramp, R; Michel, A; Seqqat, R | 1 |
Boegehold, MA; Falck, JR; Marvar, PJ | 1 |
Arbab, AS; Chen, P; Edwards, PA; Falck, JR; Guo, AM; Roman, RJ; Scicli, AG | 1 |
Coviello, A; de Bruno, MP; Jerez, S; Sierra, L | 1 |
Akhtar, S; Benter, IF; Dahly-Vernon, AJ; Dunn, KM; Roman, RJ; Yousif, MH | 1 |
Certíková Chábová, V; Cervenka, L; Falck, JR; Hammock, BD; Imig, JD; Kompanowska-Jezierska, E; Kopkan, L; Kramer, HJ; Kujal, P; Sadowski, J; Vanecková, I; Vanourková, Z; Vernerová, Z; Walkowska, A | 1 |
Abraham, NG; Cheng, J; Falck, JR; Goli, M; Gotlinger, K; Inoue, K; Schwartzman, ML; Sodhi, K; Wu, CC | 1 |
Barden, A; Beilin, LJ; Croft, KD; Puddey, IB; Tsai, IJ | 1 |
Cheng, J; Ding, Y; Falck, JR; Garcia, V; Ramu, E; Schwartzman, ML; Thakar, K; Wu, CC | 1 |
Davis, DD; Lima, R; Reckelhoff, JF; Yanes, LL | 1 |
Csiszar, A; Deak, F; Gautam, T; Koller, A; Mitschelen, M; Sonntag, WE; Sosnowska, D; Tarantini, S; Toth, P; Tucsek, Z; Ungvari, Z | 1 |
Csiszar, A; Gautam, T; Koller, A; Schwartzman, ML; Sonntag, WE; Sosnowska, D; Toth, P; Tucsek, Z; Ungvari, Z | 1 |
Didion, SP; Falck, JR; Fan, F; Maier, KG; Pabbidi, MR; Roman, RJ; Sun, CW; Williams, JM; Zhuo, J | 1 |
Bernstein, KE; Capdevila, JH; Dakarapu, R; Ding, Y; Falck, JR; Garcia, V; Gotlinger, K; Joseph, G; Schwartzman, ML; Shkolnik, B; Zhang, FF | 1 |
Gu, Y; Han, Y; OʼRourke, ST; Qi, G; Qian, SY; Shen, X; Sun, C; Xuan, C; Yao, F; Zeng, Q; Zhao, H | 1 |
Abraham, NG; Gotlinger, K; Jiang, H; Maher, E; O'Hanlon, K; Peterson, SJ; Shapiro, JI; Singh, SP; Sodhi, K; Vanella, L | 1 |
Hu, G; Ito, O; Kohzuki, M; Miura, T; Muroya, Y; Ogawa, Y; Rong, R; Wang, W | 1 |
Bar, A; Chlopicki, S; Enggaard, C; Hansen, PBL; Jasztal, A; Jensen, B; Kieronska-Rudek, A; Kij, A; Marczyk, B; Mateuszuk, L; Matyjaszczyk-Gwarda, K; Proniewski, B; Przyborowski, K; Tworzydlo, A; Walczak, M | 1 |
2 review(s) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and angiotensin ii
Article | Year |
---|---|
Endothelial dysfunction: its role in hypertensive coronary disease.
Topics: Angiotensin II; Antihypertensive Agents; Arginine; Coronary Disease; Endothelium, Vascular; Humans; Hydroxyeicosatetraenoic Acids; Hypertension; Nitric Oxide; Oxidants | 2005 |
Oxidized HDL is a potent inducer of adipogenesis and causes activation of the Ang-II and 20-HETE systems in human obese females.
Topics: Adipocytes; Adipogenesis; Adiponectin; Adult; Angiotensin II; Blood Pressure; Body Mass Index; Case-Control Studies; F2-Isoprostanes; Female; Gene Expression Regulation; Heme Oxygenase-1; Humans; Hydroxyeicosatetraenoic Acids; Lipoproteins, LDL; Metabolic Syndrome; Middle Aged; Obesity; Primary Cell Culture; Tumor Necrosis Factor-alpha | 2016 |
32 other study(ies) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and angiotensin ii
Article | Year |
---|---|
Effect of angiotensin II on the apical K+ channel in the thick ascending limb of the rat kidney.
Topics: Angiotensin II; Animals; Cell Membrane; Cytochrome P-450 Enzyme Inhibitors; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fatty Acids, Unsaturated; Hydroxyeicosatetraenoic Acids; In Vitro Techniques; Loop of Henle; Naphthalenes; NG-Nitroarginine Methyl Ester; Patch-Clamp Techniques; Penicillamine; Potassium Channel Blockers; Potassium Channels; Rats; Rats, Sprague-Dawley; S-Nitroso-N-Acetylpenicillamine; Sodium | 1996 |
ANG II controls Na(+)-K+(NH4+)-2Cl- cotransport via 20-HETE and PKC in medullary thick ascending limb.
Topics: Angiotensin II; Animals; Arachidonic Acid; Carrier Proteins; Hydroxyeicosatetraenoic Acids; Kidney Medulla; Loop of Henle; Male; Osmolar Concentration; Protein Kinase C; Rats; Rats, Sprague-Dawley; Sodium-Potassium-Chloride Symporters | 1998 |
20-Hydroxyeicosatetraenoic acid mediates calcium/calmodulin-dependent protein kinase II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells.
Topics: Angiotensin II; Animals; Arachidonic Acid; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calcium-Calmodulin-Dependent Protein Kinases; Cells, Cultured; Cytochrome P-450 Enzyme System; Enzyme Activation; Epidermal Growth Factor; Hydroxyeicosatetraenoic Acids; Lipoxygenase; Male; Muscle, Smooth, Vascular; Phospholipases A; Phospholipases A2; Rabbits | 1998 |
Angiotensin II inhibits HCO-3 absorption via a cytochrome P-450-dependent pathway in MTAL.
Topics: 5,8,11,14-Eicosatetraynoic Acid; 8-Bromo Cyclic Adenosine Monophosphate; Acid-Base Equilibrium; Angiotensin II; Animals; Benzoquinones; Bicarbonates; Cyclic AMP; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Genistein; Hydroxyeicosatetraenoic Acids; Kidney Medulla; Lactams, Macrocyclic; Loop of Henle; Male; Nitric Oxide; Protein Kinase C; Protein-Tyrosine Kinases; Quinones; Rats; Rats, Sprague-Dawley; Rifabutin; Signal Transduction; Sodium | 1999 |
Contribution of cytochrome P-450 omega-hydroxylase to altered arteriolar reactivity with high-salt diet and hypertension.
Topics: Acetylcholine; Amides; Angiotensin II; Animals; Arterioles; Blood Pressure; Cardiovascular Agents; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Fatty Acids, Unsaturated; Hydroxyeicosatetraenoic Acids; Hypertension, Renal; Male; Microscopy, Video; Mixed Function Oxygenases; Muscle, Skeletal; Nitroprusside; Oxygen; Perfusion; Rats; Rats, Sprague-Dawley; Sodium Chloride, Dietary; Sulfones | 2000 |
Angiotensin II modulates ion transport in rat proximal tubules through CYP metabolites.
Topics: Adrenalectomy; Angiotensin II; Animals; Arachidonic Acid; Cyclooxygenase Inhibitors; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dexamethasone; Dose-Response Relationship, Drug; Fatty Acids, Unsaturated; Hydroxyeicosatetraenoic Acids; Indomethacin; Ion Transport; Kidney Tubules, Proximal; Losartan; Male; Ouabain; Rats; Rats, Sprague-Dawley; Rubidium Radioisotopes | 2000 |
Angiotensin II releases 20-HETE from rat renal microvessels.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Arachidonic Acids; Arterioles; Capillaries; Cytochrome P-450 Enzyme System; Estrenes; Gas Chromatography-Mass Spectrometry; Hydroxyeicosatetraenoic Acids; Imidazoles; Kidney; Losartan; Male; NADP; Phosphodiesterase Inhibitors; Pyridines; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Type C Phospholipases | 2000 |
20-Hydroxyeicosatetraenoic acid mediates angiotensin ii-induced phospholipase d activation in vascular smooth muscle cells.
Topics: Angiotensin II; Animals; Arachidonic Acids; Cells, Cultured; Ceramides; Cyclohexanones; Enzyme Inhibitors; Glycerophospholipids; Hydroxyeicosatetraenoic Acids; Isoenzymes; Male; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; Oligonucleotides, Antisense; Organophosphonates; Phospholipase D; Propranolol; Rabbits | 2001 |
Involvement of cytochrome P450 metabolites in the vascular action of angiotensin II on the afferent arterioles.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Arachidonic Acid; Arterioles; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fatty Acids, Unsaturated; Hydroxyeicosatetraenoic Acids; Male; Miconazole; Norepinephrine; Rabbits; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Renal Circulation; Vascular Resistance; Vasoconstriction; Vasoconstrictor Agents | 2001 |
Role of 20-hydroxyeicosatetraenoic acid in the renal and vasoconstrictor actions of angiotensin II.
Topics: Amides; Angiotensin II; Animals; Arachidonic Acid; Blood Pressure; Cytochrome P-450 CYP4A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Hydroxyeicosatetraenoic Acids; Hypertension; Kidney; Male; Mixed Function Oxygenases; Rats; Rats, Sprague-Dawley; Renal Circulation; Sulfones; Triazoles; Vasoconstriction; Vasoconstrictor Agents | 2002 |
Regulation of renal microvascular 20-hydroxyeicosatetraenoic acid (20-HETE) levels.
Topics: Angiotensin II; Animals; Cytochrome P-450 Enzyme System; Hydroxyeicosatetraenoic Acids; Kidney; Rats; Renal Circulation; Sodium Chloride, Dietary | 2003 |
Cytochrome P450 arachidonic acid metabolites modulate renal tubular function.
Topics: Angiotensin II; Animals; Arachidonic Acid; Calcium; Cytochrome P-450 Enzyme System; Hydroxyeicosatetraenoic Acids; Kidney Tubules; Rats | 2003 |
Soluble epoxide hydrolase is a main effector of angiotensin II-induced hypertension.
Topics: Adamantane; Amides; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Diuresis; Epoxide Hydrolases; Hydroxyeicosatetraenoic Acids; Hypertension; In Vitro Techniques; Lauric Acids; Male; Mice; Mice, Inbred Strains; Natriuresis; Renal Circulation; Solubility; Sulfones; Vasoconstrictor Agents; Vasodilation | 2005 |
Fenofibrate prevents the development of angiotensin II-dependent hypertension in mice.
Topics: Angiotensin II; Animals; Blood Pressure; Cytochrome P-450 CYP4A; Cytochrome P-450 Enzyme System; Fenofibrate; Hydroxyeicosatetraenoic Acids; Hypertension; Kidney; Male; Mice; Mice, Inbred C57BL; Vasoconstrictor Agents | 2005 |
Contribution of arachidonic acid metabolites derived via cytochrome P4504A to angiotensin II-induced neointimal growth.
Topics: Angiotensin II; Animals; Arachidonic Acid; Carotid Arteries; Carotid Artery Injuries; Catheterization; Cells, Cultured; Cytochrome P-450 Enzyme System; Cytochrome P450 Family 4; Hydroxyeicosatetraenoic Acids; Leukocyte Common Antigens; Male; Oligonucleotides, Antisense; Rats; Rats, Sprague-Dawley; Tunica Intima | 2005 |
Increased renal vascular reactivity to ANG II after unilateral nephrectomy in the rat involves 20-HETE.
Topics: Adaptation, Physiological; Amidines; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Cyclooxygenase 1; Cyclooxygenase Inhibitors; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme System; Dinoprostone; Hydroxyeicosatetraenoic Acids; Imidazoles; Indomethacin; Losartan; Male; Microcirculation; Nephrectomy; Norepinephrine; Pyridines; Rats; Rats, Wistar; Renal Circulation; Vasoconstriction; Vasoconstrictor Agents | 2006 |
High dietary salt reduces the contribution of 20-HETE to arteriolar oxygen responsiveness in skeletal muscle.
Topics: Angiotensin II; Animals; Arterioles; Hydroxyeicosatetraenoic Acids; Indomethacin; Male; Models, Animal; Muscle, Skeletal; Muscle, Smooth, Vascular; Norepinephrine; Oxygen; Rats; Rats, Sprague-Dawley; Sodium, Dietary; Vasoconstriction | 2007 |
Activation of vascular endothelial growth factor through reactive oxygen species mediates 20-hydroxyeicosatetraenoic acid-induced endothelial cell proliferation.
Topics: Acetophenones; Angiotensin II; Blotting, Western; Cell Line; Cell Proliferation; Dose-Response Relationship, Drug; Endothelial Cells; Enzyme Activation; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Humans; Hydroxyeicosatetraenoic Acids; Hypoxia-Inducible Factor 1, alpha Subunit; Reactive Oxygen Species; Signal Transduction; Superoxides; Umbilical Veins; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2007 |
Endothelial dysfunction and improvement of the angiotensin II-reactivity in hypercholesterolemic rabbits: role of cyclooxygenase metabolites.
Topics: Acetylcholine; Angiotensin II; Animals; Aorta, Thoracic; Cholesterol, Dietary; Cyclooxygenase 1; Dose-Response Relationship, Drug; Electrophysiology; Endothelium, Vascular; Hydroxyeicosatetraenoic Acids; Hypercholesterolemia; Male; Nitric Oxide; Rabbits; Vasoconstriction; Vasoconstrictor Agents | 2008 |
Role of 20-hydroxyeicosatetraenoic acid in altering vascular reactivity in diabetes.
Topics: Amidines; Angiotensin II; Animals; Blood Glucose; Body Weight; Carbachol; Cytochrome P-450 CYP4A; Diabetes Mellitus, Experimental; Endothelin-1; Enzyme Inhibitors; Histamine; Hydroxyeicosatetraenoic Acids; Kidney; Male; Mesenteric Arteries; Microsomes; Nitroprusside; Norepinephrine; Perfusion; Rats; Rats, Wistar; Renal Artery; Triazoles; Vasoconstriction; Vasodilation | 2009 |
Combined inhibition of 20-hydroxyeicosatetraenoic acid formation and of epoxyeicosatrienoic acids degradation attenuates hypertension and hypertension-induced end-organ damage in Ren-2 transgenic rats.
Topics: 8,11,14-Eicosatrienoic Acid; Amides; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Drug Evaluation, Preclinical; Hydroxyeicosatetraenoic Acids; Hypertension; Male; Multiple Organ Failure; Norepinephrine; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Renal Circulation; Sulfones; Vasoconstrictor Agents | 2010 |
CYP4A2-induced hypertension is 20-hydroxyeicosatetraenoic acid- and angiotensin II-dependent.
Topics: Amidines; Analysis of Variance; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Blotting, Western; Cells, Cultured; Cytochrome P-450 Enzyme System; Endothelium, Vascular; Hydroxyeicosatetraenoic Acids; Hypertension; Lentivirus; Lisinopril; Losartan; Mass Spectrometry; Oligonucleotide Array Sequence Analysis; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Reverse Transcriptase Polymerase Chain Reaction; Time Factors | 2010 |
20-Hydroxyeicosatetraenoic acid synthesis is increased in human neutrophils and platelets by angiotensin II and endothelin-1.
Topics: Adult; Aged; Amidines; Angiotensin II; Angiotensin Receptor Antagonists; Biphenyl Compounds; Blood Platelets; Calcium Channels; Cells, Cultured; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Endothelin-1; Humans; Hydroxyeicosatetraenoic Acids; Imidazoles; Ionophores; Irbesartan; Male; Middle Aged; Neutrophils; Oligopeptides; Peptides, Cyclic; Piperidines; Pyridines; Tetrazoles; Young Adult | 2011 |
Induction of angiotensin-converting enzyme and activation of the renin-angiotensin system contribute to 20-hydroxyeicosatetraenoic acid-mediated endothelial dysfunction.
Topics: Acetylcholine; Angiotensin II; Cells, Cultured; Endothelial Cells; Enzyme Induction; Humans; Hydroxyeicosatetraenoic Acids; I-kappa B Kinase; Peptidyl-Dipeptidase A; Protein-Tyrosine Kinases; Renin-Angiotensin System; Superoxides | 2012 |
Roles played by 20-HETE, angiotensin II and endothelin in mediating the hypertension in aging female spontaneously hypertensive rats.
Topics: Aging; Angiotensin II; Animals; Blood Pressure; Endothelins; Female; Hydroxyeicosatetraenoic Acids; Hypertension; Rats; Rats, Inbred SHR | 2013 |
Age-related autoregulatory dysfunction and cerebromicrovascular injury in mice with angiotensin II-induced hypertension.
Topics: Actins; Adaptation, Physiological; Aging; Angiotensin II; Animals; Behavior, Animal; Blood-Brain Barrier; Cerebrovascular Circulation; Cytokines; Disease Models, Animal; Hydroxyeicosatetraenoic Acids; Hypertension; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microvessels; Middle Cerebral Artery; TRPC Cation Channels; TRPC6 Cation Channel; Up-Regulation | 2013 |
Role of 20-HETE, TRPC channels, and BKCa in dysregulation of pressure-induced Ca2+ signaling and myogenic constriction of cerebral arteries in aged hypertensive mice.
Topics: Aging; Angiotensin II; Animals; Calcium; Calcium Signaling; Hydroxyeicosatetraenoic Acids; Hypertension; Large-Conductance Calcium-Activated Potassium Channel alpha Subunits; Male; Mice; Mice, Inbred C57BL; Middle Cerebral Artery; Muscle Contraction; Muscle, Smooth, Vascular; TRPC Cation Channels; Vasoconstriction | 2013 |
20-Hydroxyeicosatetraenoic acid contributes to the inhibition of K+ channel activity and vasoconstrictor response to angiotensin II in rat renal microvessels.
Topics: Angiotensin II; Animals; Calcium; Gene Expression; Hydroxyeicosatetraenoic Acids; Ionomycin; Male; Microvessels; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Phospholipases A2; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Calcium-Activated; Rats; Receptors, Angiotensin; Renal Circulation; Type C Phospholipases; Vasoconstrictor Agents | 2013 |
Angiotensin II receptor blockade or deletion of vascular endothelial ACE does not prevent vascular dysfunction and remodeling in 20-HETE-dependent hypertension.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Cytochrome P-450 Enzyme System; Dihydrotestosterone; Disease Models, Animal; Endothelial Cells; Endothelium, Vascular; Female; Hydroxyeicosatetraenoic Acids; Hypertension; Male; Mice, Transgenic; Microvessels; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Time Factors; Vascular Remodeling | 2015 |
20-Hydroxyeicosatetraenoic Acid Is a Key Mediator of Angiotensin II-induced Apoptosis in Cardiac Myocytes.
Topics: Angiotensin II; Animals; Apoptosis; Cells, Cultured; Hydroxyeicosatetraenoic Acids; Myocytes, Cardiac; Rats; Rats, Wistar | 2015 |
Angiotensin II upregulates CYP4A isoform expression in the rat kidney through angiotensin II type 1 receptor.
Topics: Angiotensin II; Animals; Arachidonic Acid; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cytochrome P-450 CYP4A; Disease Models, Animal; Gene Expression Regulation; Humans; Hydroxyeicosatetraenoic Acids; Hypertension; Kidney; Protein Isoforms; Rats; Receptor, Angiotensin, Type 1; RNA, Messenger; Tetrazoles | 2018 |
Thrombin Inhibition Prevents Endothelial Dysfunction and Reverses 20-HETE Overproduction without Affecting Blood Pressure in Angiotensin II-Induced Hypertension in Mice.
Topics: Angiotensin II; Animals; Antithrombins; Chromatography, Liquid; Dabigatran; Disease Models, Animal; Hydroxyeicosatetraenoic Acids; Hypertension; Intercellular Adhesion Molecule-1; Male; Mice; Nitric Oxide; Tandem Mass Spectrometry; Vascular Remodeling; von Willebrand Factor | 2021 |